Kabra Drugs Share Price
BSE: 524322 | Pharmaceuticals | Small Cap
Kabra Drugs Annualised Returns
Kabra Drugs Annualised Returns
Kabra Drugs Share Price Today
Kabra Drugs Share Price Today
As of 31 Oct 2026, Kabra Drugs share price is ₹16.4. The stock opened at ₹16 and had closed at ₹15.7 the previous day. During today’s trading session, Kabra Drugs share price moved between ₹15.67 and ₹16.49, with an average price for the day of ₹16.08. Over the last 52 weeks, the stock has recorded a low of ₹15.30 and a high of ₹35.52. In terms of performance, Kabra Drugs share price has declined by 34.1% over the past six months and has declined by 16.7% over the last year.
Kabra Drugs Stock Performance
Kabra Drugs Share Price Chart
Kabra Drugs Share Price Chart
Kabra Drugs Company background
Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, highquality and accessible to every family it serves. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence.Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. The key strength comes from the development of new formulated speciality products, addressing critical therapeutic needs.Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have been undertaken by the Company.
Kabra Drugs Financial Highlights
As of 31 October 2026, Kabra Drugs’s market capitalization reached at ₹38.81 crores. Shareholding as of 31 October 2026 shows public at 100%.
Kabra Drugs Fundamental
Market Cap (in crs)
38.81
Face Value
10
Turnover (in lacs)
9.81
Key Metrics
Kabra Drugs Technical Analysis
Delivery & Volume
Delivery Volume %
Day
80.70%
Week
71.60%
Month
71.80%
Resistance & Support
Kabra Drugs Peer comparison
CompareIndex Name | Market Price |
|---|---|
16.37 +0.65 (+4.13%)▲ | |
35.95 +0.64 (+1.81%)▲ | |
54.88 -0.91 (-1.63%)▼ | |
6.21 -0.24 (-3.72%)▼ | |
0.35 -0.01 (-2.78%)▼ | |
54.48 +2.59 (+4.99%)▲ | |
26.50 +1.25 (+4.95%)▲ |
Kabra Drugs Latest News
Kabra Drugs Share Price FAQs
You can easily buy Kabra Drugs shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Kabra Drugs share price is ₹35.52 and ₹15.3 as of 30/10/2026.
Please be aware that Kabra Drugs stock prices are subject to continuous fluctuations due to various factors.